The Hospital Clínic announcement, part of its Flash CDB educational series, describes using GC/MS alongside LC-MS/MS to broaden the detection and measurement of substances that may be involved.
Confirming and extending screening
The laboratory’s service catalogue explains that mass spectrometry can confirm presumptive immunoassay findings and extend screening. Its scope includes less commonly tested substances such as ketamine, scopolamine and GHB, as well as new psychoactive substances.
Specialist laboratory work
The service distinguishes targeted analysis from non-targeted searches for substances. These methods require sample preparation and specifically trained staff; they are professional laboratory procedures.
Context matters
The announcement gives no case totals and provides no evidence about the effectiveness of home-testing products.
The date refers to the linked original publication. This summary preserves the context at that date.
← Back to the archive